Interferon alpha and half-dose sorafenib is an effective treatment modality for interferon alpha-resistant metastatic renal cell carcinoma : a case report

Metastatic renal cell carcinoma is notoriously resistant to chemotherapy and radiotherapy. Immunotherapy with interferon alpha is widely used for the disease, but its treatment effects are poor. A 69-year-old Japanese women presented with gross hematuria. Imaging studies revealed a left renal tumor,...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 55(2009), 6 vom: 09. Juni, Seite 323-6
1. Verfasser: Furuya, Nobutaka (VerfasserIn)
Weitere Verfasser: Kamai, Takao, Tokui, Noriko, Abe, Hideyuki, Fukabori, Yoshitatsu, Yoshida, Ken-ichiro
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2009
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Case Reports Journal Article Review Antineoplastic Agents Benzenesulfonates Immunologic Factors Interferon-alpha Phenylurea Compounds Pyridines Niacinamide mehr... 25X51I8RD4 Sorafenib 9ZOQ3TZI87